During the past decade, Hospital Sultanah Aminah conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 4 clinical trials were completed, i.e. on average, 14.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sultanah Aminah" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Ministry of Health, Malaysia" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sultanah Aminah" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Australasian Kidney Trials Network" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sultanah Aminah" are "Generalized Pustular Psoriasis" (3 trials), "Atrial Fibrillation" (1 trials), "Beta-Thalassemia" (1 trials), "Beta-thalassemia" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Hospital Sultanah Aminah" in a lesser frequency.

Most popular intervention types in "Hospital Sultanah Aminah" are "Drug" (23 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Spesolimab" (3 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sultanah Aminah" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Sultanah Aminah". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hospital Sultanah Aminah, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sultanah Aminah, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".